PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Research suggests that the psychedelic drug MDMA, an empathogenic stimulant also known as Molly or ecstasy, can spark changes in the brain that induce a childlike state of neuroplasticity and help forge new neural connections.
(It could well be approved for PTSD by the U.S. Food and Drugs Administration in August after two advanced stage trials showed significant benefits.)
Researchers are also studying other psychedelics as well, like the powerful drug ibogaine.
Read moreMDMA therapy for PTSD could become a new treatment option for millions of people living with trauma. The clinical evidence is growing.
Read moreA new study shows that the psychedelic drug ibogaine shows preliminary promise for traumatic brain injury.
Read moreCan psychedelics restore consciousness after brain trauma?
Researchers explore the potential of psychedelic therapies for people in minimally conscious states.
Read moreReports of the clinical effects of psychedelic therapy — loosening memories and habits that are deeply embedded — are stacking up.
Read moreVeterans are turning to psychedelic treatments for PTSD healing.
Read moreParents’ trauma can leave biological traces in their children.
Adverse experiences can change future generations through epigenetic pathways.
Read moreCheck out this interview with Amber Capone of VETS, on studying ibogaine and 5-MeO-DMT for traumatic brain injuries.
MDMA shows new promise for trauma, but the drug alone is not a cure. Research shows that MDMA, paired with intensive therapy and hard work, dramatically improves PTSD symptoms.
Read more